Mayumi Yumoto

Title: Mayumi Yumoto: Innovator in NK1 Receptor Antagonist Composition

Introduction

Mayumi Yumoto is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmacology, particularly with her innovative work on NK1 receptor antagonists. Her research focuses on developing compositions that can be utilized in various medical and therapeutic applications.

Latest Patents

Mayumi Yumoto holds a patent for an NK1 receptor antagonist composition. This composition utilizes maltooligosaccharide, which exhibits NK1 receptor antagonistic activity as its active ingredient. The formulation allows for a blending of maltooligosaccharide in amounts ranging from 0.000001 to 70% by weight. The NK1 receptor antagonist composition is designed for use in various forms, including external agents, internal medicines, foods, and beverages. It is noted for its high safety profile and satisfactory therapeutic effects, making it suitable for pharmaceutical applications.

Career Highlights

Mayumi Yumoto is associated with Lion Corporation, where she continues to advance her research and development efforts. Her work has garnered attention for its potential impact on therapeutic practices and patient care.

Collaborations

Some of her notable coworkers include Takuya Uozumi and Satoru Morishita, who contribute to her research endeavors and collaborative projects.

Conclusion

Mayumi Yumoto's innovative work in NK1 receptor antagonist compositions highlights her significant role in advancing pharmacological research. Her contributions are paving the way for new therapeutic options in medicine.